Published in Obesity and Diabetes Week, July 13th, 2009
"Our aim was to investigate in vivo the effects of a specific 11 beta-HSD1 inhibitor (2922) on atherosclerosis while assessing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.